As an example, the REDUCE Score incorporates comorbidities (COPD, congestive heart failure, renal failure) and blood parameters (hemoglobin, albumin) and takes prior ED visits (in the past 90 days) into account to highlight cancer patients at increased risk for side effects and ED visits [11]. This evidence concerns the gene ALB and acute kidney injury.